It is a paper private limited company based in Thane, Maharashtra, India, established in 2024.
2024 | Thane, Maharashtra, India | ActiveMeggle India Pharma Excipients Private Limited, a active private limited company, was established on 28 June 2024 in Thane, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21009MH2024PTC427943. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹2.89 M.
Its leadership includes Vishal Gulshan Vig (Director), Pawan Sudhakar Zade (Managing Director), Ruth Leinenbach (Additional Director). Past directors included Rushak Anil Tadkalkar, Pawan Sudhakar Zade, Thomas Pilgram. It is based at Office No. 2215 And 2216, 72/4, 72/5, 72/6, Solus Building, Thane, Maharashtra, 400607.
U21009MH2024PTC427943
427943
28 June 2024
₹4.50 M
₹2.89 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Meggle India Pharma Excipients Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Gulshan Vig | Director | 28 Jun 2024 | Current |
| Pawan Sudhakar Zade | Managing Director | 25 Nov 2024 | Current |
| Ruth Leinenbach | Additional Director | 09 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jan 2025 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2025 | Past |
| Pramod Abcsdd | Director | 07 Jan 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Meggle India Pharma Excipients's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Meggle India Pharma Excipients's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Meggle India Pharma Excipients, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Meggle India Pharma Excipients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meggle India Pharma Excipients's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ruth Leinenbach was appointed as a Additional Director was appointed as a Additional Director on 09 Sep 2025 & has been associated with this company since 2 months 22 days . was documented.
The activity Pawan Sudhakar Zade was appointed as a Managing Director was appointed as a Managing Director on 25 Nov 2024 & has been associated with this company since 1 year 4 days . was completed.
The activity Vishal Gulshan Vig was appointed as a Director was appointed as a Director on 28 Jun 2024 & has been associated with this company since 1 year 5 months . was completed.
Progress on Meggle India Pharma Excipients Private Limited was registered on 28 Jun 2024 with Roc Mumbai & aged 1 year 5 months as per MCA records. was documented.
The CIN of Meggle India Pharma Excipients Private Limited is U21009MH2024PTC427943.
Meggle India Pharma Excipients Private Limited is headquartered at Office No. 2215 And 2216, 72/4, 72/5, 72/6, Solus Building, Thane, Maharashtra, 400607.
Meggle India Pharma Excipients Private Limited was incorporated on 28 June 2024.
The current directors of Meggle India Pharma Excipients Private Limited are
The primary industry of Meggle India Pharma Excipients Private Limited is Paper.
Meggle India Pharma Excipients Private Limited is unlisted.
The authorized capital of Meggle India Pharma Excipients Private Limited is ₹4.50 M, and the paid-up capital is ₹2.89 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX